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Abstract
AIM: To investigate the influence of a positive proximal 
margin in total gastrectomy patients with gastric 
adenocarcinoma of the cardia.
METHODS: Medical records of 191 patients with total 
gastrectomies for adenocarcinoma of the cardia between 
1995 and 2000 were reviewed. The clinicopathologic 
features associated with a posit ive margin were 
determined, and the predictors for survival were 
analyzed.
RESULTS: The incidence of positive proximal margin was 
8.4% (16/191). The positive margins were associated 
with advanced diseases. The tumor size and the depth 
of tumor invasion were independent risk factors for a 
positive margin. The mean survival in the positive margin 
group was 33.9 mo as compared with 62.4 mo in the 
negative group (P  < 0.001). However, the difference in 
survival lost significance in subgroup analysis according 
to stage. Multivariate analysis identified that a positive 
margin was not an independent prognostic factor for 
survival.
CONCLUSION: A posit ive margin is more of an 
indicat ion of advanced disease in pat ients with 
gastric adenocarcinoma of the cardia rather than an 
independent prognostic factor for survival.
© 2006 The WJG Press. All rights reserved.
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INTRODUCTION
A curative resection is the only treatment offering hope for 
cure in patients with gastric cancer. This suggests removing 
the primary lesion with an adequate tumor-free margin[1,2]. 
Several reports have looked into the detrimental effect of  
a positive margin on survival in gastric cancer patients[3-5]. 
However, these studies have included heterogeneous 
groups with respect to the resection margins. Patients with 
various tumor locations of  gastric cancer or with proximal 
and distal margins of  various types of  gastrectomies are 
grouped together. 
Gastric cancer of  the cardia has been regarded as a 
separate neoplasm because of  its distinct prognostic and 
pathological features[6]. A positive proximal resection 
margin poses a management dilemma for surgeons. To 
our knowledge, there are few reports on the influence 
of  a positive proximal margin in total gastrectomy 
for adenocarcinoma of  the cardia, and there is some 
controversy as to whether a posit ive margin is an 
independent prognostic factor for survival or not.
The aim of  this retrospective study was to investigate 
the risk factors associated with a positive proximal margin 
in gastric adenocarcinoma of  the cardia, and to assess the 
influence of  a positive margin on the patient’s long-term 
survival, as well as its independent impact on prognosis. 
MATERIALS AND METHODS
Medical records were reviewed of  202 patients with 
adenocarcinoma of  the cardia undergone surgery between 
September 1995 and December 2000 at the Department 
of  Surgery, Yonsei University College of  Medicine. Two 
patients with recurrent gastric cancer, 2 with preoperative 
metastatic findings and 7 with incomplete data were 
excluded from the analysis. Therefore, 191 patients who 
underwent total gastrectomy with curative intent for gastric 
adenocarcinoma of  the cardia, were enrolled in the study. 
One hundred and twenty-nine patients (67.5%) were males 
and 62 patients were females. The median age was 57 years 
ranging from 29 to 85 years. 
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The location of  tumor and preoperative staging were 
determined by esophagoduodenogastroscopy, upper 
gastrointestinal barium examination and abdominal 
CT scan. All patients had either a type II or III tumor 
according to the Siewert classifications[7]. A total gastrect-
omy with transhiatal resection of  the distal esophagus 
and esophagojejunostomy were perfor med and a 
macroscopically tumor free proximal resection margin 
was achieved on all patients. Intraoperative frozen 
section margin evaluation was not routinely carried out 
except in patients with suspicion of  obtaining a positive 
margin and thus was not analyzed. During the operation, 
one hundred and twenty-five of  these patients (65.4%) 
underwent splenectomy for the purpose of  lymph node 
dissection or suspicion of  direct tumor invasion to the 
spleen. A D2 lymphadenectomy was regularly performed. 
In our institute, postoperative fluorouracil-based adjuvant 
chemotherapy was usually given in advanced cancer 
patients except for those with T2N0M0 stage. 
A resection margin was considered positive if  the 
permanent section examination revealed cancer infiltration 
at the line of  the transection. The length of  the resection 
margin was defined as the distance from the proximal 
limit of  the lesion to the site of  the resection. Collected 
data included patient demographics, clinicopathologic 
features and survivals. Stage was reported according to the 
fifth version of  the UICC/AJCC guidelines. Survival was 
measured from the date of  operation to death or to the 
last follow-up date of  June 30, 2003. Of  the 191 patients, 
88 (46.1%) died during the follow-up period.
Statistical analyses were performed using SPSS version 
10.0 (SPSS, Chicago, IL, USA). Univariate analysis was 
done using two-tailed c2 test or unpaired Student’s t-test. 
The risk factors associated with a positive margin were 
identified using a logistic regression model. Survival 
probability was estimated using the Kaplan-Meier method. 
The survival curves were compared using the log-rank test. 
The prognostic factors for survival were analyzed using the 
Cox proportional hazards regression model with forward 
stepwise method. P < 0.05 was considered statistically 
significant.
RESULTS
Sixteen out of  the 191 patients (8.4%) had a positive 
margin. The incidence of  this event was 26.5% (9/34) in 
patients with stage IV gastric cancer, while 10.5% (6/57) 
in stage III and 2.3% (1/43) in stage II. None of  the 57 
patients with stage I disease had a positive margin. The 
mean length of  the proximal resection margin was 2.5 ± 
1.1 cm (range, 0.8-7.0 cm). It was 2.6 ± 1.4 cm (range, 
0.8-6.5 cm) in the positive group as compared with 2.5 ± 1.2 
cm (range, 0.8-7.0 cm) in the negative margin group (P = 
0.703). A positive margin was significantly associated with 
Borrmann III and IV gross type, large size of  the primary 
tumor, serosal invasion, node involvement and advanced 
stage disease (Table 1, Table 2). Logistic regression analysis 
revealed that the size of  the primary tumor and the depth 
of  tumor invasion were independent risk factors for a 
positive margin (Table 3).
The mean follow-up time and survival time after 
surgery were 44.3 mo (range, 0.5-93.5 mo) and 59.9 mo 
(95% confidence interval, 54.6-65.1 mo), respectively. 
Table 1  Comparison of demographic and pathologic data 
between patients with positive and negative margins  n  (%)
Table 2  Comparison of tumor, node, metastasis classification, 
stage between patients with positive and negative margins  n  (%)
Variable               Positive margins        Negative margins       P  value
                                   (n  = 16)   (n = 175)
Age (years) 49.3 ± 12.7 57.5 ± 11.2 0.006
Sex 0.161
   Male   8 (50.0) 121 (69.1)
   Female   8 (50.0)   54 (30.9)
Siewert type 0.141
   Type II   5 (31.3)   25 (14.3)
   Type III 11 (68.7) 150 (85.7)
Gross type 0.001
   Borrmann I, II   1 (6.3)   83 (47.4)
   Borrmann III, IV 15 (93.7)   92 (52.6)
Tumor size (cm) 0.001
   ≤ 5 cm   2 (12.5)   98 (56.0)
   > 5 cm 14 (87.5)   77 (44.0)
Histology 0.399
   Differentiated   3 (18.8)   56 (32.0)
   Undifferentiated 13 (81.2) 119 (68.0)
LRM (cm) 0.985
   ≤2   4 (25)   42 (24.0)
   > 2 and ≤ 4 10 (62.5) 113 (64.6)
   > 4   2 (12.5)   20 (11.4)
LRM: length of resection margin. Age represents mean ± SD.
Variable                       Positive margins   Negative margins    P  value
                                          (n  = 16)      (n  = 175)
Depth of tumor invasion < 0.001
   T1   0 (0) 29 (16.6)
   T2   2 (12.5) 84 (48.0)
   T3 11 (68.7) 55 (31.4)
   T4   3 (18.8)   7 (4.0)
Node involvement < 0.001
   N0   3 (18.8) 67 (38.3)
   N1   2 (12.5) 60 (34.3)
   N2   2 (12.5) 26 (14.8)
   N3   9 (56.2) 22 (12.6)
Stage < 0.001
   I   0 (0) 57 (32.6)
   II   1 (6.3) 42 (24.0)
   III   6 (37.5) 51 (29.1)
   IV   9 (56.2) 25 (14.3)
Table 3  Logistic regression analysis of risk factors for a positive 
margin
Variable          Regression  Standard   Odds      95% CI for         P
          coefficient    error      ratio        odds ratio         value
Serosal invasion 2.300 0.782 9.970 2.152 - 46.196 0.003
Tumor size 1.875 0.787 6.524 1.395 - 30.512 0.017
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On univariate analysis, the gross type, size of  the primary 
tumor, serosal invasion, lymph node involvement, stage, 
resection margin status and splenectomy were significantly 
associated with the long-term survival. The mean survival 
time in patients with positive margins was 33.9 mo as 
compared with 62.4 mo in patients with negative margins (P 
< 0.001, Figure 1A). Since fifteen out of  16 patients (93.8%) 
with positive margins had stage III and IV gastric cancer in 
the present study, we then analyzed the subgroup patients 
stratified by stage, the difference in survival between 
both groups did not reach significance in stage III and IV 
gastric cancer (Figure 1B). 
On multivariate analysis, seven variables with a 
significance level of  < 0.05 in univariate analysis were 
included in the model. Positive margin was not identified 
to be an independent predictor for survival (Table 4). 
DISCUSSION
The incidence of  positive resection margin has been re-
ported to vary from 5% to 35%[8-10]. In this study, the inci-
dence of  this event was 8.4%. However, it was significantly 
higher in patients with stage III and IV gastric cancer 
(16.5%) than in patients with stage I and II gastric cancer 
(1.0%). There are several factors accounting for such a 
high incidence of  positive margin in advanced gastric can-
cer patients. First, it has been reported that the incidence 
of  positive margin increases with deeper invasion of  the 
tumor into the gastric wall and advanced disease stage[11,12]. 
Secondly, patients with stage III and IV disease have more 
Borrmann III and IV gross type of  tumors and/or more 
undifferentiated tumors (data not shown), and these pa-
tients may have a higher risk of  sub-clinical intramural 
tumor infiltration to the esophagus[10]. Finally, intraop-
erative frozen section margin evaluation is not routinely 
performed in advanced disease patients, which may pos-
sibly increase the incidence of  a positive margin in those 
patients[13]. 
The risk factors for a positive margin in the present 
study were identified based on the same length of  the 
proximal resection margin between margin positive and 
negative groups. Logistic regression analysis showed that 
the risk mainly depended on the depth of  cancer invasion 
and the size of  the primary tumor.
The depth of  invasion into the gastric wall is signifi-
cantly related to a higher rate of  esophageal infiltration. 
Bozzetti et al[14] reported that the risk of  proximal infiltra-
tion is significantly higher when the tumor infiltrates the 
serosa or beyond it. Songun et al[14] demonstrated that 
the depth of  tumor invasion is one of  the independent 
prognostic factors for a positive margin in gastric cancer 
at various tumor locations. Our results are similar to the 
aforementioned reports. The size of  the primary tumor 
was also identified as an independent predictor for a posi-
tive margin, which is in agreement with that reported by 
Yokoda et al[16], who found that a lesion exceeding 5 cm in 
maximum diameter is predisposed to a positive margin in 
gastric cancer. 
Although frozen section has a high sensitivity and spec-
ificity, it is not routinely used to assess the resection mar-
gin[3,17,18]. It is advisable that this technique should be used 
selectively for patients who may benefit from it since fro-
zen sections are costly and time-consuming[19]. Our study 
observed that patients with advanced stage disease had a 
higher risk of  obtaining a positive margin. In addition, a 
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Figure 1  Cumulative survival curves according to the margin status in a total of 191 patients (A) and 91 stage III and IV (B) patients with gastric cancer of the cardia. The 
mean survival time of patients with positive margins was 33.9 mo compared to 62.4 mo of patients with negative margins in total 191 patients, and 29.2 mo compared to 
38.2 mo in 91 patients with stage III and IV diseases
Table 4  Multivariate analysis of prognostic factors for survival
Variable               Regression Standard  Odds     95% CI for      P
               coefficient   error     ratio       odds ratio     value
Gross type -0.174 0.258 0.840 0.507 - 1.392 0.500
Tumor size  0.209 0.248 1.232 0.758 - 2.001 0.399
Serosal invasion -0.125 0.264 0.883 0.526 - 1.481 0.637
Node involvement  0.838 0.431 2.311 0.994 - 5.374 0.052
Stage  1.469 0.389 4.344 2.028 - 9.304 < 0.001
Margin status  0.397 0.330 1.488 0.779 - 2.843 0.229
Splenectomy  0.276 0.292 1.318 0.744 - 2.337 0.344
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positive margin was associated with deeper tumor invasion 
to the gastric wall and larger tumor size. These findings 
may provide some evidence for helping the surgeons select 
patients to perform intraoperative frozen section margin 
evaluation.
The influence of  a positive margin on prognosis of  
gastric cancer of  the cardia remains controversial. Chan 
et al[20] reviewed 137 total or proximal gastrectomies for 
gastric cancer with various lesion sites and observed that a 
positive oesophageal margin is an independent poor prog-
nostic factor for long-term survival. A similar result has 
been reported by Mariette et al[21], who reviewed 94 adeno-
carcinomas of  the esophagogastric junction, but different 
surgical approaches were involved in their work. In addi-
tion, there are no difference in the clinicopathologic fea-
tures between the positive margin group and the negative 
margin group in the study[21]. These aforementioned stud-
ies are not in accordance with the results we observed that 
a positive margin was not associated with the long-term 
survival in gastric adenocarcinoma of  the cardia. This dis-
crepancy, although has to be interpreted with caution, may 
be explained by the following reasons. First, it was a ret-
rospective study and the analyses were based on relatively 
few patients with or without positive margins in our single 
institution. Second, a positive margin is often associated 
with advanced disease. Gall et al[22] investigated 87 patients 
who underwent esophagectomy for cancer and found that 
the positive margin is involved mainly in late stage disease 
which does not influence the long-term survival in those 
patients. Kim et al[23] reported that a positive margin loses 
its predictive value for survival in patients with T3 or T4 
lesions and stage III or IV disease. Finally, because the 
relationship between margin status and treatment failure 
patterns were not addressed in our study with the limited 
data, our results may possibly due to the uncertainty in 
advanced disease, the patients may usually succumb to 
metastatic disease before the effect of  the positive margin 
is observed[24]. 
Our results suggest that a positive margin is more of  
an indication of  advanced disease rather than an indepen-
dent prognostic factor for survival in patients with gastric 
cancer of  the cardia. However, more definitive conclusions 
would be based on multi-center studies with the results of  
large-scale analyses. 
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